338 related articles for article (PubMed ID: 8551594)
1. Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside.
Tenser RB; Gaydos A; Hay KA
J Virol; 1996 Feb; 70(2):1271-6. PubMed ID: 8551594
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of herpes simplex virus reactivation by dipyridamole in a mouse model.
Hay KA; Gaydos A; Tenser RB
J Med Virol; 1996 Oct; 50(2):198-203. PubMed ID: 8915888
[TBL] [Abstract][Full Text] [Related]
3. Secondary herpes simplex virus latent infection in transplanted ganglia.
Tenser RB; Edris WA; Gaydos A; Hay KA
J Virol; 1994 Nov; 68(11):7212-20. PubMed ID: 7933103
[TBL] [Abstract][Full Text] [Related]
4. Neuronal control of herpes simplex virus latency.
Tenser RB; Edris WA; Hay KA
Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
[TBL] [Abstract][Full Text] [Related]
5. Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir.
Field HJ; Lay E
Antiviral Res; 1984 Apr; 4(1-2):43-52. PubMed ID: 6331304
[TBL] [Abstract][Full Text] [Related]
6. Role of herpes simplex virus thymidine kinase expression in viral pathogenesis and latency.
Tenser RB
Intervirology; 1991; 32(2):76-92. PubMed ID: 1851146
[TBL] [Abstract][Full Text] [Related]
7. Thymidine Kinase-Negative Herpes Simplex Virus 1 Can Efficiently Establish Persistent Infection in Neural Tissues of Nude Mice.
Huang CY; Yao HW; Wang LC; Shen FH; Hsu SM; Chen SH
J Virol; 2017 Feb; 91(4):. PubMed ID: 27974554
[TBL] [Abstract][Full Text] [Related]
8. Low-level expression and reversion both contribute to reactivation of herpes simplex virus drug-resistant mutants with mutations on homopolymeric sequences in thymidine kinase.
Griffiths A; Link MA; Furness CL; Coen DM
J Virol; 2006 Jul; 80(13):6568-74. PubMed ID: 16775343
[TBL] [Abstract][Full Text] [Related]
9. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
Coen DM; Irmiere AF; Jacobson JG; Kerns KM
Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
[TBL] [Abstract][Full Text] [Related]
10. The role of herpes simplex thymidine kinase expression in neurovirulence and latency in newborn vs. adult mice.
Hay KA; Gaydos A; Tenser RB
J Neuroimmunol; 1995 Aug; 61(1):41-52. PubMed ID: 7560011
[TBL] [Abstract][Full Text] [Related]
11. Replication, latent infection, and reactivation in neuronal culture with a herpes simplex virus thymidine kinase-negative mutant.
Wilcox CL; Crnic LS; Pizer LI
Virology; 1992 Mar; 187(1):348-52. PubMed ID: 1310559
[TBL] [Abstract][Full Text] [Related]
12. Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia.
Wang K; Mahalingam G; Hoover SE; Mont EK; Holland SM; Cohen JI; Straus SE
J Virol; 2007 Jul; 81(13):6817-26. PubMed ID: 17459924
[TBL] [Abstract][Full Text] [Related]
13. Recurrent acyclovir-resistant herpes simplex in an immunocompromised patient: can strain differences compensate for loss of thymidine kinase in pathogenesis?
Horsburgh BC; Chen SH; Hu A; Mulamba GB; Burns WH; Coen DM
J Infect Dis; 1998 Sep; 178(3):618-25. PubMed ID: 9728528
[TBL] [Abstract][Full Text] [Related]
14. Reactivation of acyclovir-resistant thymidine kinase-deficient herpes simplex virus harbouring single base insertion within a 7 Gs homopolymer repeat of the thymidine kinase gene.
Morfin F; Thouvenot D; Aymard M; Souillet G
J Med Virol; 2000 Oct; 62(2):247-50. PubMed ID: 11002255
[TBL] [Abstract][Full Text] [Related]
15. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
Saijo M; Suzutani T; Yoshida I
Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
[TBL] [Abstract][Full Text] [Related]
16. Latency-associated transcript but not reactivatable virus is present in sensory ganglion neurons after inoculation of thymidine kinase-negative mutants of herpes simplex virus type 1.
Tenser RB; Hay KA; Edris WA
J Virol; 1989 Jun; 63(6):2861-5. PubMed ID: 2542595
[TBL] [Abstract][Full Text] [Related]
17. Expression of extremely low levels of thymidine kinase from an acyclovir-resistant herpes simplex virus mutant supports reactivation from latently infected mouse trigeminal ganglia.
Besecker MI; Furness CL; Coen DM; Griffiths A
J Virol; 2007 Aug; 81(15):8356-60. PubMed ID: 17522225
[TBL] [Abstract][Full Text] [Related]
18. Translational compensation of a frameshift mutation affecting herpes simplex virus thymidine kinase is sufficient to permit reactivation from latency.
Griffiths A; Chen SH; Horsburgh BC; Coen DM
J Virol; 2003 Apr; 77(8):4703-9. PubMed ID: 12663777
[TBL] [Abstract][Full Text] [Related]
19. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.
Coen DM; Kosz-Vnenchak M; Jacobson JG; Leib DA; Bogard CL; Schaffer PA; Tyler KL; Knipe DM
Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4736-40. PubMed ID: 2543985
[TBL] [Abstract][Full Text] [Related]
20. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis.
Efstathiou S; Kemp S; Darby G; Minson AC
J Gen Virol; 1989 Apr; 70 ( Pt 4)():869-79. PubMed ID: 2543763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
